-
1
From 1990 to 2021, China saw 105,670 new leukemia cases, with acute lymphoblastic leukemia (ALL) having the highest burden among subtypes.
-
2
Chronic myeloid leukemia (CML) exhibited the greatest declines in incidence, deaths, and disability-adjusted life years (DALYs) compared to other subtypes.
-
3
Age-standardized incidence rates (ASIRs) for acute myeloid leukemia (AML) and CML declined, while ALL and chronic lymphocytic leukemia (CLL) showed increasing trends.
-
4
Age was identified as the primary determinant of leukemia incidence, with distinct age distributions and cohort patterns observed across the subtypes.
-
5
Future projections indicate stable rates for AML and CML, a gradual decline for ALL, and a continued rise for CLL through 2046, necessitating targeted strategies.
